Cardiac Science To Present At The BMO Capital Markets Focus On Healthcare Conference

BOTHELL, Wash., Nov. 29 /PRNewswire-FirstCall/ -- Cardiac Science Corporation , a global leader in advanced cardiac monitoring and defibrillation products, announced today that it will present at the BMO Capital Markets Focus on Healthcare Conference at the Millennium Broadway Hotel in New York on Wednesday, December 6, 2006, at 4:00 p.m. Eastern Time. Michael Matysik, chief financial officer, will be discussing recent business accomplishments and related financial information regarding Cardiac Science.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGO )

Attendance at the conference is by invitation only. Cardiac Science will offer a live audio webcast of its presentation, which may be accessed at the Company’s website at www.cardiacscience.com. An archived replay of the presentation will also be available approximately 48 hours following the live presentation and will be available at www.cardiacscience.com.

About Cardiac Science Corporation

Cardiac Science is truly at the heart of saving lives. The Company develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including AEDs, electrocardiographs, stress test systems, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, patient monitor - defibrillators and cardiology data management systems. Cardiac Science also sells a variety of related products and consumables, and provides a comprehensive portfolio of training, maintenance and support services. The Company is the successor to various entities that have owned and operated cardiology-related businesses that sold products under the trusted brand names Burdick(R), Powerheart(R), and Quinton(R). Cardiac Science is headquartered in Bothell, WA, and also has operations in Lake Forest, California; Deerfield, Wisconsin; Shanghai, China and Manchester, United Kingdom.

Company Contact: Mike Matysik Cardiac Science Corporation Sr. Vice President and CFO 425-402-2009 Investor Contact: EVC Group, Inc. Douglas Sherk/Jenifer Kirtland 415-896-6820 Media Contact: EVC Group, Inc. Jen Saunders 646-201-5431

Photo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk photodesk@prnewswire.comCardiac Science Corporation

CONTACT: Mike Matysik Sr. Vice President and CFO of Cardiac ScienceCorporation, +1-425-402-2009; or investors, Douglas Sherk or JeniferKirtland, +1-415-896-6820, or media, Jen Saunders, +1-646-201-5431, both ofEVC Group, Inc., for Cardiac Science Corporation

MORE ON THIS TOPIC